Key terms
About GSK
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest GSK news
Yesterday
12:38pm ET
GSK to Divest Final Shares in Haleon
Yesterday
6:58am ET
GSK Finalizes Exit from Haleon with £1.2B Sale
May 16
11:46am ET
GSK announces intention to sell about 385M shares in Haleon
May 14
12:30pm ET
GSK Executives Invest in Company’s Future
May 14
10:26am ET
GSK, Abu Dhabi partner to establi regional vaccine distribution hub
May 13
12:29pm ET
GSK Reports Latest Securities Allotment Status
May 13
8:26am ET
GlaxoSmithKline (GSK) Gets a Buy from Jefferies
May 09
8:16am ET
Wave Life Sciences appoints Erik Ingelsson as CSO
May 08
2:57pm ET
GSK’s 24th AGM Sees High Approval Rates
May 08
1:57pm ET
GSK Announces Key Board Committee Changes
May 08
10:26am ET
Pfizer agrees to settle over 10,000 Zantac cancer suits, Bloomberg reports
May 03
11:27am ET
GSK Executive Sells Shares on London Exchange
May 03
9:28am ET
Moderna price target raised to $155 from $125 at Jefferies
May 02
2:47pm ET
GSK price target raised to 1,660 GBp from 1,530 GBp at JPMorgan
May 01
1:58pm ET
GSK Forecasts a Year of Strong Growth
May 01
12:35pm ET
GSK Pharma put volume heavy and directionally bearish
May 01
12:01pm ET
GSK Updates Share Capital and Voting Rights
May 01
6:26am ET
GSK raises 2024 core EPS growth view to 8%-10% from 6%-9%
May 01
6:23am ET
GSK reports Q1 core EPS 43.1p, up 28% at CER
Apr 30
11:45am ET
GSK Pharma call volume above normal and directionally bullish
Apr 30
10:13am ET
FTC expands patent listing challenges for drugs
Apr 24
7:57am ET
GSK’s Jemperli Awaits FDA Expansion Approval
Apr 24
7:56am ET
CureVac, GSK terminate Pandemic Preparedness Agreement
Apr 24
7:29am ET
CureVac, GSK announce start of Phase 1 part of investigational H5N1 trial
Apr 24
7:29am ET
CureVac announces start of Phase 1/2 study in avian influenza
Apr 24
6:25am ET
GSK: FDA accepts expanded Jemperli indication application for priority review
Apr 23
8:34am ET
Wave Life Sciences announces continued momentum in GSK collaboration
Apr 19
6:21pm ET
VGK vs. EZU: Which Is the Better European Stock ETF?
Apr 19
11:57am ET
GSK Executives Reinforce Commitment via Share Purchase
Apr 17
11:57am ET
GSK Executives Reinvest Dividends in Shares
Apr 17
10:40am ET
Analysts Offer Insights on Healthcare Companies: Agilent (A), GlaxoSmithKline (GSK) and Stryker (SYK)
No recent press releases are available for GSK
GSK Financials
Key terms
Ad Feedback
GSK Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
GSK Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
